Abikhzer Myriam, Delouya Guila, Taussky Daniel
Occupational Therapy, University McGill, Montreal, CAN.
Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, CAN.
Cureus. 2024 Sep 19;16(9):e69743. doi: 10.7759/cureus.69743. eCollection 2024 Sep.
Rita Levi-Montalcini (RLM) is recognized as a prestigious and renowned researcher of her time. She was the fourth woman to earn the Nobel Prize in Physiology and Medicine in 1986 for the discovery of nerve growth factor (NGF). We review her biography and scientific discovery, and provide an example of why her discovery is still important. She had a special relationship with McGill University, Canada, which we describe. We searched for articles and books about her for biographical and scientific material and met with Dr. Claudio Cuello, Former Chair of McGill's Faculty of Medicine. RLM was born in 1909 in Turin, Italy, where she had studied medicine. She started her career in research. Because of the anti-Jewish racial laws in Italy in 1938, she went underground and continued her projects in her bedroom. After the war, she visited St. Louis, USA, and conducted research there. Her experiments confirmed that tumors release a factor that causes nerve growth and cancer proliferation. Initially, scientists responded to this discovery with skepticism, but after its purification in 1959 and determination of its protein structure in 1971, NGF became widely accepted. Currently, crosstalk between cancers and nerves is poorly understood. The example of prostate cancer shows that surgical or chemical denervation of sympathetic nerves prevents the initiation of prostate tumors, whereas inhibition of parasympathetic nerve signaling reduces the spread of prostate cancer. McGill University awarded RLM a doctoral degree in 2011. It was the first time in its history that the University awarded an honorary doctorate outside of Canada, and the second one outside of Quebec. Through her discovery of NGF, RLM exemplified the power of passion and determination despite the obstacles she faced. Her relentless dedication has led to remarkable achievements.
丽塔·列维-蒙塔尔奇尼(RLM)被公认为她那个时代享有盛誉且声名远扬的研究员。她是1986年因发现神经生长因子(NGF)而获得诺贝尔生理学和医学奖的第四位女性。我们回顾她的生平及科学发现,并举例说明她的发现为何至今仍很重要。我们讲述了她与加拿大麦吉尔大学的特殊关系。我们搜索了关于她的文章和书籍以获取生平及科学资料,并采访了麦吉尔大学医学院前院长克劳迪奥·奎洛博士。RLM于1909年出生在意大利都灵,她在那里学习医学。她开启了自己的研究职业生涯。由于1938年意大利的反犹种族法律,她转入地下,在自己的卧室继续她的项目。战后,她前往美国圣路易斯并在那里开展研究。她的实验证实肿瘤会释放一种导致神经生长和癌症增殖的因子。最初,科学家们对这一发现持怀疑态度,但在1959年该因子被提纯以及1971年其蛋白质结构被确定后,NGF被广泛接受。目前,癌症与神经之间的相互作用仍知之甚少。前列腺癌的例子表明,交感神经的手术或化学去神经支配可防止前列腺肿瘤的发生,而抑制副交感神经信号传导则可减少前列腺癌的扩散。麦吉尔大学于2011年授予RLM博士学位。这是该校历史上首次在加拿大境外授予荣誉博士学位,也是在魁北克境外授予的第二个荣誉博士学位。通过她对NGF的发现,RLM展现了尽管面临重重障碍,但激情和决心所具有的力量。她不懈的奉献带来了卓越的成就。